Serum Liver Fatty Acid Binding Protein Levels Correlate Positively with Obesity and Insulin Resistance in Chinese Young Adults

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Shi, Juan ^a   Zhang, Yifei ^a   Gu, Weiqiong ^a   Cui, Bin ^b   Xu, Min ^a   Yan, Qun ^a   Wang, Weiqing ^a   Ning, Guang ^a,b   Hong, Jie ^a  

^a SHANGHAI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; ENERGY BALANCE; FATTY ACID METABOLISM; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; OBESITY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84868680639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048777     Document Type: Article

References (34)

1. Boord JB, Fazio S, Linton MF, (2002) Cytoplasmic fatty acid-binding proteins: emerging role in metabolism and atherosclerosis. Curr Opin Lipidol 13: 141-147.
2. Coe NR, Bernlohr DA, (1998) Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1391: 287-306.
3. Glatz JFC, Van der Vusse GJ, Veerkamp JH, (1988) Fatty acid-binding proteins and their physiological significance. New Physiol Sci 3: 41-43.
4. McArthur MJ, Atshaves BP, Frolov A, Foxworth WD, Kier AB, et al. (1999) Cellular uptake and intracellular trafficking of long chain fatty acids. J Lipid Res 40: 1371-1383.
5. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067.
6. Haunerland NH, Spener F, (2004) Fatty acid-binding proteins - insights from genetic manipulations. Prog Lipid Res 43: 328-349.
7. Xu A, Wang Y, Xu JY, Stejskal D, Tam S, et al. (2006) Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52: 405-413.
8. Chmurzynska A, (2006) The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 47: 39-48.
9. Rolf B, Oudenampsen-Krüger E, Börchers T, Faergeman NJ, Knudsen J, et al. (1995) Analysis of the ligand binding properties of recombinant bovine liver-type fatty acid binding protein. Biochim Biophys Acta 1259: 245-253.
10. Martin GG, Danneberg H, Kumar LS, Atshaves BP, Erol E, et al. (2003) Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. J Biol Chem 278: 21429-21438.
11. Newberry EP, Xie Y, Kennedy S, Han X, Buhman KK, et al. (2003) Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J Biol Chem 278: 51664-51672.
12. Martin GG, Atshaves BP, McIntosh AL, Mackie JT, Kier AB, et al. (2006) Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice. Am J Physiol Gastrointest Liver Physiol 290: G36-48.
13. Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO, (2006) Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44: 1191-1205.
14. Newberry EP, Kennedy SM, Xie Y, Sternard BT, Luo J, et al. (2008) Diet-induced obesity and hepatic steatosis in L-Fabp -/- mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation. Am J Physiol Gastrointest Liver Physiol 294: G307-314.
15. Derikx JP, Poeze M, van Bijnen AA, Buurman WA, Heineman E, (2007) Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 28: 544-548.
16. Gollin G, Marks C, Marks WH, (1993) Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery 113: 545-551.
17. Kanda T, Fujii H, Tani T, Murakami H, Suda T, et al. (1996) Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110: 339-343.
18. Lieberman JM, Sacchettini J, Marks C, Marks WH, (1997) Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers an intestinal ischemia. Surgery 121: 335-342.
19. Thuijls G, van Wijck K, Grootjans J, Derikx JP, van Bijnen AA, et al. (2011) Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg 253: 303-8.
20. Consultation WE, (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
21. Hong J, Gui MH, Gu WQ, Zhang YF, Xu M, et al. (2008) Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose. Diabet Med 25: 73-79.
22. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, et al. (1994) A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43: 1114-1121.
23. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) (2001) JAMA. 285: 2486-2497.
24. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
25. Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, et al. (2010) Liver fatty acid-binding protein and obesity. J Nutr Biochem 21: 1015-32.
26. Storch J, Thumser AE, (2000) The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486: 28-44.
27. Fisher E, Weikert C, Klapper M, Lindner I, Möhlig M, et al. (2007) L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab 91: 278-84.
28. Peng XE, Wu YL, Lu QQ, Hu ZJ, Lin X (2012) Two genetic variants in FABP1 and susceptibility to non-alcohol fatty liver disease in a Chinese population. Gene [Epub ahead of print].
29. Weickert MO, Loeffelholz CV, Roden M, Chandramouli V, Brehm A, et al. (2007) A Thr94Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects. Am J Physiol Endocrinol Metab 293: E1078-84.
30. Kamijo-Ikemori A, Sugaya T, Yasuda T, Kawata T, Ota A, et al. (2011) Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care 34: 691-6.
31. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL, (2004) Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 89: 4607-4614.
32. Engels W, van Bilsen M, Wolffenbuttel BH, van der Vusse GJ, Glatz JF, (1999) Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid binding protein content in liver, heart, and kidney of the diabetic rat. Mol Cell Biochem 192: 53-61.
33. Morrow FD, Allen CE, Martin RJ, (1979) Intracellular fatty acid-binding protein: Hepatic levels in lean and obese rats. Fed Proc 38: 280.
34. Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K, (2008) Amelioration of diabetic tubulointerstitial damage in liver type fatty acid binding protein transgenic mice. Nephrol Dial Transplant 24: 788-800.